Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-10), Tego Science's Beta is 0.2632.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Tego Science Beta Related Terms
Tego Science Beta Historical Data
* Premium members only.
The historical data trend for Tego Science's Beta can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Tego Science's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tego Science Beta vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tego Science's Beta distribution charts can be found below:
* The bar in red indicates where Tego Science's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Tego Science (XKRX:191420) has a Beta of 0.2632 as of Aug. 10, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tego Science and its competitors.
Is Tego Science's Beta too high?
Tego Science's current Beta is 0.2632. Overall, Tego Science has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tego Science's Beta compare to ZTS?
Tego Science's Beta of 0.2632 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tego Science and its competitors. Tego Science's current Beta is 0.2632. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tego Science stock overvalued right now?
Based on GuruFocus' analysis, Tego Science (XKRX:191420) is currently considered Possible Value Trap. The stock's GF Value™ is ₩13,243.11, compared to a current price of ₩7,140.00 — trading 46.1% below its estimated fair value. The current Beta is 0.2632. Tego Science's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Tego Science (XKRX:191420), the current Beta is 0.2632 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tego Science (XKRX:191420) Overvalued in 2026?
Based on GuruFocus' analysis, Tego Science stock appears to be undervalued.
The current stock price of ₩7,140.00 is trading 46.1% below its estimated GF Value™ of ₩13,243.11.
GuruFocus considers Tego Science to be Possible Value Trap.
Key valuation signals for XKRX:191420:
Beta: 0.2632
GF Value™: ₩13,243.11 vs. price of ₩7,140.00 (46.1% below fair value)
No single metric tells the full story. See the XKRX:191420 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tego Science Inc is a biotech company that researches and develops regenerative medicine. It is engaged in the production of epidermis and cornea wound healing solution. Its products include Holoderm, SkinBank, Kaloderm, and Neoderm. It also provides testing services.
56GF Score
Get the complete analysis for XKRX:191420
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:191420 has been successfully added to your 
